Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Secondary Prevention of Coronary Heart Disease: Clopidogrel Could Be the Better Option – Deutsches Ärzteblatt

Summary by Deutsches Ärzteblatt
Lugano – Acetylsalicylic acid (ASA) has traditionally been considered the standard treatment for people with coronary heart disease (CHD). A meta-analysis based on data from nearly 29,000 affected patients now shows that clopidogrel monotherapy provides more effective protection against cardiovascular events without increasing the risk of bleeding. The results were published in...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Deutsches ÄrzteblattDeutsches Ärzteblatt

Secondary Prevention of Coronary Heart Disease: Clopidogrel Could Be the Better Option – Deutsches Ärzteblatt

Lugano – Acetylsalicylic acid (ASA) has traditionally been considered the standard treatment for people with coronary heart disease (CHD). A meta-analysis based on data from nearly 29,000 affected patients now shows that clopidogrel monotherapy provides more effective protection against cardiovascular events without increasing the risk of bleeding. The results were published in...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Deutsches Ärzteblatt broke the news in on Wednesday, September 3, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Lugano icon

Lugano

News
For You
SearchBlindspotLocal